Besponsa

List of products in the National Drug Code with proprietary name besponsa. This medication is used to treat a certain type of cancer (acute lymphoblastic leukemia-ALL). It works by slowing or stopping the growth of cancer cells.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0008-0100Besponsa Inotuzumab OzogamicinInjection, Powder, Lyophilized, For SolutionIntravenousWyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.Human Prescription Drug